Precigen (PGEN) Change in Receivables (2012 - 2026)
Precigen's (PGEN) quarterly Change in Receivables came in at $22.5 million in Q1 2026, up 12949.71% year-on-year from N/an in Q1 2025, and up 574.07% on a QoQ basis from $3.3 million in Q4 2025.
Precigen (PGEN) Change in Receivables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Change in Receivables data on file, last reported at $22.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables rose 12949.71% year-over-year to $22.5 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a 21300.0% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 12358.33% from the prior year.
- Change in Receivables for Q1 2026 stood at $22.5 million, up from $3.3 million in the prior quarter.
- Over the last five years, Change in Receivables for PGEN reached as high as $22.5 million in Q1 2026 and fell as low as -$4.6 million in Q3 2022.
- Historically, Change in Receivables has averaged $1.6 million across 5 years, with a median of -$32000.0 in 2024.
- Across the five-year window, Change in Receivables slumped 483.33% in 2025 and surged 12949.71% in 2026, its largest moves.
- Year by year, Change in Receivables stood at -$271000.0 in 2022, then soared by 68.27% to -$86000.0 in 2023, then surged by 619.77% to $447000.0 in 2024, then surged by 646.31% to $3.3 million in 2025, then surged by 574.07% to $22.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $22.5 million in Q1 2026, $3.3 million in Q4 2025, and $253000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 22.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.49 Mn |
| Mar 31, 2026 | 22.49 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 253,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | -424,000.00 |
| Jun 30, 2025 | -424,000.00 |
| Mar 31, 2025 | -175,000.00 |
| Mar 31, 2025 | -175,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -86,000.00 |
| Dec 31, 2023 | -86,000.00 |